Our immune system protects us but when it comes to some mosquito-borne disease, it can work against us. What are the implications for the development of a Zika virus vaccine?
Academic rigor, journalistic flair
Articles on Zika vaccine
Displaying all articles
In the future, consumers in the developed world could choose to purchase products from the companies that do the most to promote global health.
Public health experts enlist the molecular biology tools that create genetically modified organisms – as well as the GMOs themselves – in the fight against emerging infectious diseases.
During a disease outbreak, lots of people can become infected in a short time and develop immunity, making it hard for the pathogen to spread.
Recently two events concerning the Zika epidemic coincided: two potential vaccines against the virus were declared a success when used in mice, and Jason Day withdrew from the Olympic Games.
Top contributors
-
Professor and Director of Doherty Epidemiology, The University of Melbourne
-
Cameron Webb is a Friend of The Conversation.
Clinical Associate Professor and Principal Hospital Scientist, University of Sydney
-
Associate Professor, Computing & Information Systems; Director, Melbourne Data Analytics Platform, The University of Melbourne
-
Professor, epidemiological modelling of infectious diseases, UNSW Sydney
-
Professor in Mathematical Biology, The University of Melbourne
-
Lecturer (University of Tasmania), University of Tasmania
-
Ph.D. Candidate in Chemical Biology, Harvard University
-
Distinguished Professor, Public Health and Medical Anthropology, University of the Witwatersrand
-
Laboratory Head, Department of Microbiology and Immunology, The University of Melbourne
-
Professor of Philosophy, Binghamton University, State University of New York
